Evaluation of Garcina indica Whole Fruit Extracts For Hypoglycemic Potential in Streptozotocin Induced Hyperglycemic Rats.


Khatib N. A.1 and Patil P. A.2

1Department of Pharmacology, K. L. E. University’s College of Pharmacy Belgaum, 59010, Karnataka                2Joint director Research foundation, K. L. E. University, Belgaum, 59010, Karnataka.

*Corresponding Author E-mail: khatibnayeem@hotmail.com



Garcinia indica (GI) whole fruit extracts i.e. aqueous, methanol and chloroform were evaluated for its hypoglycemic activity in oral glucose tolerance in glucose loaded euglycemic rats and in streptozotocin (STZ) 50mg/kg induced hyperglycemic rats. Acute treatment of aqueous extract (400mg/kg) markedly improved oral glucose tolerance in glucose (3g/kg) loaded euglycemic rats. Treatment of aqueous extract (400mgmg/kg) in STZ induced hyperglycemic rats showed significant (p<0.0001) reduction in the fasting blood glucose levels both in acute and chronic study, indicating its antihyperglycemic activity. Methanol and chloroform extracts treatment do not showed significant hypoglycemic activity. The result of the present study indicates aqueous extract of GI whole fruit posess significant hypoglycemic activity in STZ induced hyperglycemic rats.


KEYWORDS: Hyperglycemia, Garcinia indica fruit, hypoglycemic activity, Streptozotocin,OGTT





Herbal drugs have served as a major source of medicine for the prevention and treatment of many diseases including diabetes mellitus1. Many herbal plant spices were showed hypoglycemic properties, including common plants such as pumpkins, wheat, celery, bitter melon2.


Diabetes mellitus is a clinically syndrome characterized by in appropriate hyperglycemia caused by lack of insulin or insulin resistance or both at the cellular level (3).  Recent analysis indicates the human population worldwide appears to be in the midst of epidemics of diabetes. Despite the great stride that have been made in the understanding and management of diabetes, the disease and disease related complications are increasing unabated4.


Ayurveda and other traditional medicine systems describe number of plants used as herbal drugs for the treatment of diabetes mellitus. The active principles present in herbal drugs have been reported to possess hypoglycemic potentials acting through different pathways5. It is also reported that plants useful in diabetes mellitus possess strong antioxidant/free radical scavenging properties6.


Garcinia indica (GI) choisy ( Clusiaceae)  fruit is an Indian spice used in many parts of the country for making various food preparations. It is a traditional home remedy in case of flatulence, heat stroke and infections. Many therapeutics effects of fruits have been described in traditional medicine based on Ayurveda. These includes as an infusion in skin ailments, burns, scalds and chaffed skin, to relive sunstroke, dysentery, mucous diarrhea, an appetizer, anthelmentic, anti ulcer, anti tumor and good liver tonic .Active constituents present in the fruit are anthocynins, fatty acids, hydroxycitric acid, garcinol. Isogarcinol, palmitic acid and linoleic acids.7-11.


There is scarcity of information regarding the studies of hypoglycemic activity of GI whole fruit in animals. Therefore, the present study was designed to evaluate hypoglycemic activity of GI whole fruit extracts in euglycemic and streptozotocin (STZ) induced hyperglycemic Wistar rats of either sex.



Plant materials: The fresh fruit of GI were collected from Sawanthwadi Maharashtra, identified and authenticated by Dr. Harsha Hedgde taxonomist RMRC (ICMR) Belgaum and a herbarium specimen was deposited with voucher No. RMRC 469. The fresh whole fruits of the plants were shade dried and reduce to powder.


Preparation of various extracts:  About 200gm of powder material defatted with pet ether (40-600C).

The aqueous extract was prepared by macerating 100 gm of defatted powder with chloroform water IP for seven days with occasional shaking at room temperature, filtered and concentrated on rotary evaporator and dried in desicator over sodium sulphite. The yield obtained was

34.80 % w/w.


Chloroform and methanol extracts were  prepared with 100 gm of defatted powder in soxhlet extractor and extracted  first with chloroform (40-60ºC) and then with methanol 95% v/v at 60ºC. Appearance of colourless solvent in the siphen tube was considered for termination of extraction process. The yield obtained was 19.44% and 30.48%w/w respectively. All the extracts were stored in refrigerator at 4ºC until further use for experimental study.


Phytochemical screening: A preliminary phytochemical analysis was carried out of all the three extracts (aqueous, methanol and Chloroform) employing the standard phytochemical procedures to reveal the presence of various phytoconstituents.


Animals:  Healthy Wistar rats (180-200g) of either sex, obtained from Venkatesh enterprises Bangalore, were used. They were maintained on standard animal pellet diet (Amrut animal feed, Sangli, Maharashtra) and water ad libitum. The present study was dully approved by IAEC  bearing Reg. NO 627/02/a/CPCSEA JN Medical College Belgaum.


Acute oral toxicity study:  Acute oral toxicity study was carried out by using Wistar rats by “fixed dose” method of OECD guideline NO. 420 and a starting dose of 2000 mg/kg body weight was adopted. There were no toxic effects or mortality observed up to 14th days with all the three extracts.


Evaluation of hypoglycemic  activity:  GI whole fruit extracts i.e. aqueous, methanol and chlorofom were screened to find out hypoglycemic effect by OGTT method and in STZ  induced hyperglycemic rats (acute and chronic model).


i) Oral glucose tolerance test (OGTT)12:

The effect of all three extracts were evaluated in glucose loaded (3g/kg) normal rats. There were total eight groups consisting each of six normal rats.  Group I served as control rats given normal saline (2ml/kg p.o). Group II served as standard treated with glibenclamide (0.9mg/kg p.o), while groups (III to V) served as test groups treated   at a dose 200mg/kg, where as groups (VI to VIII) treated at a dose of 400mg/kg  i.e aqueous, methanol and chloroform extracts respectively.


After fasting for 12-16 hrs all animals in each group were orally administered vehicles, glibenclamide or the different extracts 30 min prior to oral glucose load (3g/kg) respectively. The blood glucose levels were estimated from each group before (0 min) extracts administered and at 30, 60, 90, 120 and 180 min after glucose challenge..

Animal groupings:

Group I;   Control [normal saline 2ml/kg]

Group II:  Standard [ glibenclamide( 0.9mg/kg) + glucose 3g/ kg]

Group III:   Test 1[ aqueous extract (200mg/kg)+ glucose 3 g/kg]

Group IV: Test 2.[ methanol extract  ( 200mg/kg) + glucose 3 g/kg]

Group V:  Test 3 [chloroform extract (200mg/kg) + glucose 3 g/kg]

Group VI: Test 1[aqueous extract (400mg/kg) + glucose 3 g/kg]

Group VII: Test 2 [ methanol extract  ( 400mg/kg) + glucose 3 g/kg]

Group VIII: Test 3 [chloroform extract (400mg/kg) + glucose 3 g/kg].


ii)  STZ induced hyperglycemic animals. At the end of   one-week acclimatization period, freshly prepared STZ at a dose of 50 mg/kg was injected intraperitonially as a single dose. Blood samples were obtained from rat tail vein on 3rd and 7th day and blood glucose was estimated by using glucometer. Rats with blood glucose levels of 200 mg/dl or more on both days were categorized as a hyperglycemic.


Hypoglycemic test:

a) Acute study design: Animals are divided in to eight groups with six in each.

Group I. Hyperglycemic (STZ induced 50mg/kg)

Group II. Hyperglycemic + glibenclamide (0.9mg/kg)

Group III. Hyperglycemic+ aqueous extract (200mg/kg)

Group IV. Hyperglycemic + methanol extract (200mg/kg)

Group V. Hyperglycemic+ chloroform extract (200mg/kg)

Group VI. Hyperglycemic+ aqueous extract (400mg/kg)

Group VII. Hyperglycemic + methanol extract (400mg/kg)

Group VIII. Hyperglycemic + chloroform extract (400mg/kg)


All STZ induced hyperglycemic  rats were fasted for 12-16 hours before they were tested for the blood glucose level. A basal glucose level (BGL) was recorded on day of experiment prior to the extract administration. Later the animals in each group were orally administered with vehicle, glibenclamide (0.9 mg) or the different extracts (200 and 400mg/kg p.o single dose).  The blood glucose levels were measured at 30, 60, 90, 120 and 180 minutes by using the glucometer.


b) Chronic study design:

GI  fruit extract showing significant hypoglycemic activity in acute study was only selected for chronic study i.e. for 30 days.   The same animals from the acute study were continued for chronic study and treatment given was as follows:


Group I:  Normal  euglycemic  (normal saline 2 ml/kg)

Group II: STZ induced hyperglycemic rats. (Normal saline 2ml/kg)

Group III: Hyperglycemic + glibenclamide (0.9 mg/kg p.o single dose)

Group IV: Hyperglycemic + aqueous extract treated (400 mg/kg p.o twice daily)


Drugs and chemicals:   Drugs and chemical used includes streptozotocin (Himedia, Mumbai), glibenclamide (Inga Laboratories Mumbai), Glucometer and glucostrips (Sugar check, Wokhardt, Mumbai).


Statistical analysis: Data was expressed as Mean ± SEM and was analyzed by two way ANOVA followed by Bonferroni post tests.  P<0.05 was considered statistically significant.



Acute toxicity: All three extracts at a dose 2000 mg/kg body wt. showed no toxic effects or mortality up to 14 days. The LD50   cut off value of the extracts was 2000 mg/kg body wt.


Selection of the dose The LD50 cut off value was found to be 2000 mg/kg body wt. For the assessment of hypoglycemic activity two doses were selected i.e. first dose 1/10th of the LD50 cut off value and second dose twice that of one tenth dose i.e. (200 and 400mg/kg respectively).


Phytochemical screening: The preliminary qualitative phytochemical screening of GI whole fruit extracts showed the presence of carbohydrates, flavonoids, alkaloids, steroids, tannins, saponins, oxalic acid, citric acid and ascorbic acid in aqueous extract. Carbohydrates, flavonoids,steroids,tannins,saponins and citric acid in methanol extract and carbohydrate,tannins,oxalic acid and citric acid in chloroform extract.


Oral glucose tolerance test: At a dose of 200 mg/kg body wt of aqueous, methanol and chloroform extracts exhibited insignificant fall in a BGL when compared with control group (Fig.1).  Acute administration of aqueous extract at dose 400 mg/kg in normal rats showed significant improvement in oral glucose tolerance following oral glucose load as shown (Fig. 2) when compared with control group. No significant fall in BGL observed in methanol and chloroform extracts treated groups.


Fig. 1: Fasting blood glucose levels of extracts treated rats in OGTT at dose 200mg/kg body wt.


Fig. 2: Fasting blood glucose levels of  various extracts treated rats in OGTT at dose 400mg/kg body wt.


Acute hypoglycemic activity:  At a dose 200mg/kg aqueous, methanol and chloroform extracts showed insignificant decreased in BGL in STZ induced hyperglycemic rats when compared with untreated hyperglycemic rats (Table 1).  400 mg/kg dose of aqueous extract showed significantly (P<0.001) decreased the BGL between 30 to 120 minutes. Whereas no significant decrease was observed in methanol and chloroform extract treated groups when compared with untreated hyperglycemic rats (Table.1). As aqueous extract at dose 400 mg/kg body wt. showed significantly decreased BGL with duration of action between 30 to 120 minute (Table.2), this dose was selected for chronic hypoglycemic activity and was administered twice daily for 30 days.


Chronic hypoglycemic activity:  Administration of GI aqueous fruit extract at a of dose 400 mg/kg twice daily in STZ induced hyperglycemic rats for 30 days significantly (P<0.001) decreased   BGL when compared with untreated hyperglycemic rats.


Pancreatic histology:  The histopathological studies of pancreas revealed severe congestion with severe decrease in number of islets of Langherhans and beta cells with   fibrosis and   inflammatory cell infiltration into the islets of Langherhans in STZ induced hyperglycemic rats. While, the   aqueous extract of GI whole fruit at a dose of 400 mg/kg showed mild congestion with mild decrease in number of islets of Langherhans with normal beta cell population indicating significant amount of recovery. Glibenclamide treatment showed moderate congestion with moderate decrease in number of islets of langherhans and beta cells and mild lymphocytic infiltration (figures are not included).



The present study was planned to evaluate hypoglycemic potential of whole fruit of GI extracts i.e aqueous, methanol and chloroform in OGTT and STZ induced hyperglycemic animals. The acute administration of aqueous extract at 400 mg/kg significantly improved oral glucose tolerance in glucose loaded normal rats indicating its antihyperglycemic activity, further acute  and chronic treatment in STZ induced hyperglycemic rats also showed significant antihyperglycemic action.

Table 1. Effect of acute treatment of various extract of GI whole fruit extracts  at dose 200 and 400 mg/kg body wt.  on STZ induced hyperglycemic rats.


Fasting     blood glucose concentration (mg/dl)

0 min

30 min

60 min

90 min

120 min

180 min

Group I

294.00± 4.99

296.30± 5.16

297.30± 4.78

298.80± 4.77

301.20± 5.53

303.70± 5.39

Group II

307.20± 4.99

286.70± 4.01

269.80± 4.05**

256.80± 4.05***

245.30± 6.95***

239.80± 5.26***

Group III

292.70± 4.04

405.20± 8.75

350.70± 9.15

319.80± 11.15

312.70± 9.08

321.00± 5.58

Group IV

290.00± 5.36

402.30± 11.22

436.00± 13.93

421.80± 20.43

400.30± 17.93

384.80± 8.20

Group V

313.50± 3.25

399.70± 4.32

420.20± 4.87

422.50± 8.22

406.70± 7.12

395.30± 5.38

Group VI

301.20± 5.990

362.00± 12.10

377.50± 6.27

356.30±### 6.52

325.70±### 3.72

335.20±### 4.56

Group VII

299.7± 6.04

348.30± 9.35

392.70± 3.52

409.70± 4.25

395.70± 2.33

381.50± 4.19

Group VIII

282.30± 2.74

336.50± 7.15

379.50± 4.41

402.00± 3.14

398.20± 4.37

391.00± 2.14

*P<0.05 when compared with group I. ** P<0.01 when compared with Group I. ***P<0.001 when compared with group I.

# P<0.05 when compared with group VII, ## P< 0.01 when compared with group VII, ### P<0.001 when compared with group VII



Table 2.Effect of chronic treatment of aqueous extract of GI whole fruit on STZ induced hyperglycemic rats.

Treatment and Groups



Fasting   blood glucose concentration (mg/dl)

0th Day

7th day

14th day

30th day

Group I

5 ml/kg





Group II

50 mg/kg





Group  III






Group IV

400 mg/kg





***P<0.001 when compared with group II.



Whereas no such significant effect were seen with methanol and chloroform extracts. phytoconstituents such as , flavonoids, tannins, polyphenols, carbohydrates, saponins and Vit.C have shown hypoglycemic activity in animal studies13,14.  The preliminary qualitative phytochemical analysis of aqueous exract showed presence of carbohydrate, steroids, flavonoids, alkaloids tannins,  citric acid and Vit.C. The hypoglycemic activity of GI fruit could be due to the presence of  these active phytoconstituents.


STZ induction causes severe selective destruction of the beta cells of the islets of langerhans through oxidative stress induced pathway.(15-17) .The histological examination in the present study showed,  STZ  (50mg/kg  i.p) single dose causes  severe destruction of the beta cells. Aqueous extract of GI whole fruit treatment demonstrated significant recovery when compared with untreated hyperglycemic rats. This could be sign of regeneration of beta cell of islets of langerhans. Glibenclamide treatment showed similar result as reported.18,19 .


From the present study it is difficult to establish the exact pathway for hypoglycemic activity.

However it could be proposed that the various phytoconstituents present in the GI fruit and the regenerating property on pancreas be responsible for the hypoglycemic activity. Further studies are required to explore the exact mechanism of action for the observed effect.



In conclusion aqueous extract of GI whole fruit at a dose 400mg/kg twice daily showed significant( P<0.0001) hypoglycemic activity in STZ induced hyperglycemic rats. Further study is required to trace out the active constituents and mechanism of action for hypoglycemic activity.



The authors are thankful to the Principal Dr. F. V.Manvi and Vice Principal Prof. A.D.Taranalli, KLE College of Pharmacy, Belgaum, Karnataka, India, for the support and constant encouragement.

Abbreviations used: GI =Garcinia indica; STZ =streptozotocin; BGL = blood glucose levels



1.        Wei Jia, et al Antidiabetic herbal drugs officially approved in China. Phytotherapy Research. 17; 2003: 1127–1134.

2.        Devendrakumar D. et al. Traditional phytotherapy for diabetes used by the people of perambalur district, tamilnadu, south India. Recent Research In Science And Technology.1(6);2009: 287–290

3.        K.A. Wadkar. et al. Anti-diabetic potential and indian medicinal plants. Journal of Herbal Medicine and Toxicology 2 (1); 2008: 45-50.

4.        Ashok K. Diabetes mellitus and multiple therapeutic approaches of phytochemicals: present status and future prospects. Current Science. 83(1); 2002: 30-38.

5.        Sarita Singh. et al A database for anti-diabetic plants with clinical/experimental trials. Bioinformation 4(6); 2009: 263-268.

6.        Ilango K. et al. Antidiabetic, antioxidant and antibacterial activities of leaf extracts of adhatoda zeylanica. medic (acanthaceae). Journal of Pharmaceutical Science. and Research. 1(2);2009: 67-73

7.        Kirikar K.R., Basu B.D. Indian Medicinal Plants, International book distributors 2nd ed., 1999; 1: 262-263.

8.        Akanksha Mishra et al. Antioxidant activity of Garcinia indica (kokam) and its syrup. Current Science. 91(1); 2006: 90-93.

9.        Kokate CK, Gokhale AS, Gokhale SB. Cultivation of medicinal plants, 2nd ed. Pune: Nirali Prakashan., 2004; p.7.53- 7.54.

10.     V. K. Raju, M. Reni. Kokam and cambodge, Handbook of herbs and spices, p. 207-214

11.     Krishnamurthy KS, Sapna VP, Chemistry of species, Chp-19: Garcinia, p. 342-356

12.     Amornnat Thuppia et al. The hypoglycemic effect of water extract from leaves of Lagerstroemia speciosa L. in streptozotocin-induced diabetic rats. Songklanakarin J. Sci. Technol.31 (2); 2009:133-137.

13.     Neelesh Malviya. et al  Antidiabetic Potential Of Medicinal Plants. Acta Poloniae Pharmaceutica Ñ Drug Research, 67(2);2010: 113-118,

14.     Mishra Shanti Bhushan et al. An Analytical Review of Plants for Anti Diabetic Activity With Their Phytoconstituent and Mechanism Of Action. International journal of pharmaceutical sciences and research.1(1); (2010):29-46.

15.     Mahmoud Abu Abeeleh. et al. Induction of diabetes mellitus in rats using intraperitoneal streptozotocin: a comparison between 2 strains of rats. European Journal of Scientific Research. 32(3) ;2009:398-402.

16.     A. Akbarzadeh et al. Induction of diabetes by streptozotocin in rats. indian Journal Of Clinical Biochemistry.22(2); 2007:60-64.

17.     T. Szkudelski. The Mechanism of alloxan and streptozotocin action in b cells of the rat pancreas. Physiological Research. 50; 2002: 536-546.

18.     Nicole S Farrar et al. Effect of a series of novel sulphonylthioureas on glucose tolerance in the obese fa/fa zucker rat. Clinical and Experimental Pharmacology And Physiology.28;2001: 386–391

19.     Gulam Mohammed Husain. Antidiabetic activity of standardized extract of Picrorhiza kurroa in rat model of NIDDM . Drug Discov Ther.3(3); 2009:88-92.






Received on 24.03.2011          Modified on 01.04.2011

Accepted on 07.04.2011         © RJPT All right reserved

Research J. Pharm. and Tech. 4(6): June 2011; Page 999-1003